Sahm Adrangi is, indeed, not a stereotypical hedge fund manager. Adrangi is, however, the man behind Kerrisdale Capital. Kerrisdale Capital is a financial support source for research. Specifically, Kerrisdale funds such research areas as aviation and biotechnology.
So far, nearly 50 investments have been made. Details concerning all of the investments have already been published on the official Kerrisdale website. Sahm Adrangi is committed to honesty and transparency. He and the Kerrisdale website are significant sources of inspiration of numerous investors. He first worked in the area of credit and put in a lot of time working with hedge funds and distressed debt.
A Noteworthy Chief Investment Officer
Sahm Adrangi is presently the CIO (chief investment officer). He is a hands-on person who oversees every aspect of the firm’s operations. He also manages the organization’s investment portfolio.
Adrangi launched the company in 2009. He started with less than $1 million. Under his handling, the fund blossomed into $150 by July of 2017. In his position as CIO, Sahm Adrangi published his own research and made additional activist investments.
Short Sale Investments
His firm has made a great number of investments in short sales. Adrangi also invested in some Chinese businesses. Adrangi considers China as a significant source of much economic growth. Adrangi shorted such companies as the China Marine Food Group which was previously known for fraud. Such businesses have been singled out for enforcement of securities laws by the SEC.
The Development Of Expertise in Biotechnology
Sahm Adrangi also is currently concentrating on the development of knowledge in certain specific fields. His company has a major focus on biotech and an involvement with allocating capital for a business. Furthering an exposure to this particular industry has greatly benefited Sahm Adrangi and his business venture.